InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.094 -0.004 (-4.08%)+
Announcement
Release
17 Nov 2025 8:24AM
Price at Release
$0.098
Full Release
download
Summary
Alcidion Group Limited announced an expansion of its contract with Leidos Australia to enhance the delivery of healthcare solutions to the Commonwealth of Australia using its Miya Precision platform. The expanded contract, valued at $12.3 million over approximately 2.7 years until June 2028, will add $2.5 million to Alcidion's Annual Recurring Revenue (ARR). The company expects to recognize between $5.5 million and $6.5 million of this revenue in the financial year 2026. This contract aligns with a larger existing agreement with Leidos, which has potential extensions until 2036.
Key Points
  • Contract expansion with Leidos Australia for Miya Precision.
  • Total contract value of $12.3M until June 2028.
  • Addition of $2.5M to Annual Recurring Revenue.
  • Revenue recognition of $5.5M-$6.5M in FY26.
  • Initial contract term aligns with existing contract extensions until 2036.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.